Future Trends in Beauty Available in new NielsenIQ (NIQ) Global Beauty Innovation Report
12.9.2024 15:00:00 CEST | Business Wire | Press release
Personal Care Brands embracing innovation in 2023 are 2.5 times more likely to see sales growth.20% of 2023 innovation launches in Europe were in skin and hair care categories.Effective activation leads to 20% lift in ad-driven sales.
In the ever-evolving beauty industry, understanding and fulfilling meaningful consumer needs has become paramount, especially following significant shifts post COVID-19. NIQ today released its Global Beauty Innovation Report, powered by NIQ BASES Innovation Measurement providing a comprehensive view of the state of innovation and future trends in the beauty industry across 14 markets.
Personal Care Brands embracing innovation in 2023 are 2.5 times more likely to see overall sales growth compared to those with stagnant or declining innovation sales. Strong innovations attract new buyers, create new usage occasions, justify price premiums, and keep brands top of mind.
Brands delivering strong products can see a significant upside, with an average Year 1 volume increase of 30% compared to their less successful counterparts. Effective activation leads to a 20% lift in ad-driven sales, especially when creative elements are optimized. This underscores the importance of having both a great product and ensuring that the marketing and promotional efforts are well-executed and resonate with the target audience.
Claire Marty, Vice President, Global Client Development, commented, “Despite increasing caution in consumer spending, consumers are less willing to cut back on their beauty expenditures compared to other FMCG products, with 80% indicating they intend to maintain or increase their spending in this area. The beauty industry's global popularity continues to rise, with industry sales maintaining a double-digit growth rate across all regions and is expected to bring an increase in scale of $300 billion over the next decade.”
Breakthrough Trends accelerating innovation in Beauty Industry:
- Clean and Sustainable: The trend towards clean and sustainable products is growing in the CPG category, focusing on ethical sourcing, eco-friendly packaging, and reducing carbon footprints. In South Korea clean beauty has become a lifestyle choice with manufacturers focusing on eco-friendly packaging and sustainable production practices.
- Ingredient Focus: Global consumers are shopping with an ‘ingredients first’ mindset, prioritizing products based on their ingredient lists. Consumers are interested both in which ingredients are included and also in which are not. UK consumers prioritize results and efficacy over brand names.
- Trusted Advisor:Celebrities, dermatologists, and influencers are shaping beauty decisions through social media. In China, the number of Key Opinion Leaders (KOLs) exceeds 20 million and is growing, while 80% of actual sales come from merely 7% of KOLs.
- Personalization and Inclusivity: Consumers increasingly prefer brands that address individual needs, leading to more tailored experiences like hair and skin quizzes. Afroconsumption is the hottest personalization and inclusivity topic in Brazil, with women opting out of hair straightening products.
- Wellness Focused: Consumers are prioritizing their well-being, leading to a demand for products that support physical, mental, and emotional health. The cosmetics industry in France is leveraging on neuroscience targeting both body and mind. Luxury brands are creating products improving both skin appearance and emotional well-being.
- Convenience and Accessibility: Direct–to-consumer (DTC) products and at-home beauty treatments surged in popularity during COVID-19. This trend continues to grow as electric cosmetics and muscle stimulation devices have surged in popularity.
Luxury for all: This trend in beauty reflects the growing availability of high-quality products at affordable prices. Democratization of luxury is driven by innovative brands offering exceptional products rivaling high-end counterparts. Consumers in Saudi Arabia value high-quality ingredients and are willing to pay a premium particularly on Personal and Beauty care. Successful activation in the beauty industry hinges on the synergy between a compelling idea and a robust product with one third of new launches faltering due to lack sufficient support during their first year.
For more insights on Beauty Trends, download a copy of the NIQ Global Beauty Innovation Report and join the Beauty inner Circle to gain premium insights. NIQ also regularly provides unique, proprietary insights across global consumer trends, including its latest SpendZ report, a comprehensive look at the spending trends of Gen Z, Consumer Outlook reports analyzing trends, behavior and sentiment.
About NIQ
NielsenIQ (NIQ) is the world’s leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. NIQ combined with GfK in 2023, bringing together the two industry leaders with unparalleled global reach. Today NIQ has operations in more than 95 countries covering 97% of GDP. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delivers the Full View™.
For more information, please visit www.niq.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240912272679/en/
Contacts
Media:
Media:
Sweta Patra
sweta.patra@nielseniq.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom